3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiac Inflammation
Cardiac inflammation, a condition characterized by inflammation of the heart tissue, plays a significant role in various cardiovascular diseases. This inflammatory response can be triggered by infections, autoimmune disorders, or other underlying health issues. When the heart becomes inflamed, it may lead to serious complications, affecting the organ's ability to pump blood effectively. Conditions such as myocarditis and pericarditis are common manifestations of cardiac inflammation, posing risks of heart failure if left untreated. Researchers and healthcare professionals are actively exploring the intricate mechanisms of cardiac inflammation to develop targeted interventions and preventive measures. Understanding and addressing cardiac inflammation are crucial steps in advancing cardiovascular health and mitigating the impact of related diseases on individuals worldwide.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain